Skip to content
GenoLensGenoLens

PAX4

Chr 7q32.1

paired box 4

Aliases:
MODY9
MANE:
ENST00000639438.3

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Moderate Evidence (Amber)

  • Neonatal diabetes

    BIALLELIC, autosomal or pseudoautosomal
  • Diabetes with additional phenotypes suggestive of a monogenic aetiology

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Familial diabetes

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Monogenic diabetes

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Multi-organ autoimmune diabetes

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

Disease associations (Open Targets)

  • type 2 diabetes mellitus

    0.68
  • diabetic ketoacidosis

    0.56
  • MODY

    0.51
  • maturity-onset diabetes of the young type 9

    0.41
  • diabetes mellitus

    0.38
  • liver disorder

    0.31
  • diabetic eye disease

    0.30
  • diabetic retinopathy

    0.30
  • uterine corpus leiomyoma

    0.25
  • cleft palate

    0.24

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Paired box protein Pax-4

DNA-binding transcription factor that plays a central role in the differentiation and development of type B pancreatic cells, which are located within the pancreatic islets of Langerhans responsible for the production and release of insulin (By similarity). Mainly acts as a transcription repressor that binds to a common element in the glucagon, insulin and somatostatin promoters and inhibits their expression (By similarity). Prevents differentiation of type A pancreatic cells, probably by repressing expression of ARX (By similarity). Competes with another transcription factor, PAX6, for this same promoter binding site (By similarity). Also plays a key role in intestinal enteroendocrine cell differentiation by (1) directly promoting differentiation of enterochromaffin cells and (2) preventing differentiation of other intestinal enteroendocrine cell types (PubMed:37883554). Prevents differentiation of other intestinal enteroendocrine cell types by repressing the expression of ARX, the master transcription factor for intestinal type-L, -N, -D, -I and -G enteroendocrine cell differentiation (PubMed:37883554)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.